Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1371, 2003-01, pp. : 15-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tenecteplase plus enoxaparin sodium: MI therapy reaches new heights in ASSENT-3
Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. :
Access to resources
Recommend
Thrombolytics: no survival benefit in patients aged > 75 years?
Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. :
Can the Time Window for Administration of Thrombolytics in Stroke be Increased?
By Donnan G.A.
CNS Drugs, Vol. 17, Iss. 14, 2003-01 ,pp. :
Rituximab plus CHOP induction beneficial in aggressive NHL
Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. :